Abstract | BACKGROUND: METHODS: RESULTS: In vitro, nafamostat mesilate inhibited activities of NF-κB, phosphorylated IκBα, ICAM-1, VEGF and MMP-9. Moreover, nafamostat mesilate not only inhibited cell adhesion and invasion but also increased the sensitivity of anoikis. In vivo, tumor growth using AsPC-1 cells of the treatment group was significantly slower, and survival rate was significantly better, than those in control group (p < 0.05). CONCLUSION:
|
Authors | Yuki Fujiwara, Kenei Furukawa, Koichiro Haruki, Yohta Shimada, Tomonori Iida, Hiroaki Shiba, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga |
Journal | Journal of hepato-biliary-pancreatic sciences
(J Hepatobiliary Pancreat Sci)
Vol. 18
Issue 5
Pg. 731-9
(Sep 2011)
ISSN: 1868-6982 [Electronic] Japan |
PMID | 21484229
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Benzamidines
- Guanidines
- Interleukin-8
- NF-kappa B
- Protease Inhibitors
- nafamostat
|
Topics |
- Animals
- Benzamidines
- Blotting, Western
- Cell Adhesion
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Enzyme-Linked Immunosorbent Assay
- Guanidines
(pharmacology)
- Humans
- Interleukin-8
(metabolism)
- Male
- Mice
- Mice, Inbred BALB C
- NF-kappa B
(antagonists & inhibitors, metabolism)
- Neoplasm Invasiveness
(pathology, prevention & control)
- Neoplasms, Experimental
(pathology)
- Pancreatic Neoplasms
(drug therapy, metabolism, pathology)
- Peritoneal Neoplasms
(metabolism, pathology, prevention & control)
- Protease Inhibitors
(pharmacology)
- Tumor Cells, Cultured
|